Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Bibliographic Data
| ID | 23345491 |
|---|---|
| Authors | Peter S Hendricks (University of Alabama at Birmingham), Christopher B Thorne (University of Alabama at Birmingham), C Brendan Clark (0000-0001-7004-4437, University of Alabama at Birmingham), David Coombs (0009-0005-9091-5515, University of Alabama at Birmingham), David W Coombs (University of Alabama at Birmingham), Matthew W Johnson (0000-0002-3741-6312, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA) |
| Year | 2015 |
| Volume | 29 |
| Issue | 3 |
| Pages | 280-288 |
| Publication date | 2015-03-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Psychopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0269-8811 • E-ISSN: 1461-7285 |
| Publisher | SAGE Publications (PUBLISHER • US) |
| DOI | 10.1177/0269881114565653 |
| PMID | 25586402 |
| OpenAlex | W1997161439 |
| Language | EN |
| Citations received | 93 |
| References cited | 52 |
Mental health problems are endemic across the globe, and suicide, a strong corollary of poor mental health, is a leading cause of death. Classic psychedelic use may occasion lasting improvements in mental health, but the effects of classic psychedelic use on suicidality are unknown. We evaluated the relationships of classic psychedelic use with psychological distress and suicidality among over 190,000 USA adult respondents pooled from the last five available years of the National Survey on Drug Use and Health (2008–2012) while controlling for a range of covariates. Lifetime classic psychedelic use was associated with a significantly reduced odds of past month psychological distress (weighted odds ratio (OR)=0.81 (0.72–0.91)), past year suicidal thinking (weighted OR=0.86 (0.78–0.94)), past year suicidal planning (weighted OR=0.71 (0.54–0.94)), and past year suicide attempt (weighted OR=0.64 (0.46–0.89)), whereas lifetime illicit use of other drugs was largely associated with an increased likelihood of these outcomes. These findings indicate that classic psychedelics may hold promise in the prevention of suicide, supporting the view that classic psychedelics’ most highly restricted legal status should be reconsidered to facilitate scientific study, and suggesting that more extensive clinical research with classic psychedelics is warranted.
Distress · Environmental health · Logistic regression · Mental distress · Mental health · Odds · Odds ratio · Population · Psychiatry · Chemical synthesis and alkaloids · Clinical Psychology · Medicine · Neurotransmitter Receptor Influence on Behavior · Psychedelics and Drug Studies · Psychology
Recruitment discrimination of lifetime classic psychedelic users is unjustified
Lifetime classic psychedelic use is associated with greater psychological distress in unemployed job seekers
A double-edged sword
Race as a component of set and setting
Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics
Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests
Epidemiology of classic psychedelic substances
Entheogenic Experience and Spirituality
Farmakológiai biopolitikák (1. rész)
Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Psilocybin with psychological support for treatment-resistant depression
Ego-Dissolution and Psychedelics
Classic psychedelics
Long-term effects of psychedelic drugs
Predicting Responses to Psychedelics
Psychedelic therapy for smoking cessation
The Challenging Experience Questionnaire
Rebus and the Anarchic Brain
Psychedelics and the essential importance of context
Psilocybin with psychological support for treatment-resistant depression
Psychedelics
Psychedelics and workplace harm
Toward a contextual psychedelic-assisted therapy
The Ethic of Access
Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder
Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being
Suicide Risk Among Cannabis, Heroin and Cocaine Users
Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder
Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample
Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study
Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the Covid-19 Confinement
The association between naturalistic use of psychedelics and co-occurring substance use disorders
Psychedelic Mushrooms in the USA
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential
Psychedelic Use and Mystical-Type Experiences are Associated With Greater Self-Compassion, Compassionate Love, and Life Satisfaction
Psychoanalyst attitudes towards psychedelic-assisted therapy
Toward a positive psychology of psychoactive drug use
Intention-Setting Among Recreational Psychedelic Users
Association Between Lifetime Hallucinogen Use and Valvular Heart Disease
Entheogenic Spirituality
Comparing Mental Health across Distinct Groups of Users of Psychedelics, MDMA, Psychostimulants, and Cannabis
A Public-Health-Based Vision for the Management and Regulation of Psychedelics
Psychedelics, Personality and Political Perspectives
Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use
The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving
Trends in the Top-Cited Articles on Classic Psychedelics
Healing Words
Religion, Psychedelics, Risky Behavior, and Violence
Spiritual Benefit from Cannabis
Exploring Self-Reported Effects of Naturalistic Psychedelic Use Among Gender and Sexual Minorities
Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia
Mixed-Methods Study of Use and Attitudes About Psychedelics for Therapeutic Purposes Among Low-Income U.S. Veterans Nationally
Exploring the Use of Psilocybin Therapy for Existential Distress
Magic Mushroom Use
Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users
Religious Social Integration, Psychedelics, and Psychological Distress
On the mushrooming reports of “quiet quitting”
Ayahuasca and Public Health
Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users
Unequal Healing
How psychedelic researchers’ self-admitted substance use and their association with psychedelic culture affect people’s perceptions of their scientific integrity and the quality of their research
Plants Don’t Have a Culture to Appropriate
Standing in the Gap
Describing the Unspeakable
Rural‐urban divide in risk perception of LSD
Hallucinations and Hallucinogens
Psychedelics and potential benefits in “healthy normals”
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting
Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States
Making “bad trips” good
Møter med det hellige
Classic Psychedelic Use and Mechanisms of Mental Health
Self-Integration after Recreational Psychedelic Use
Of Roots and Fruits
Psychological Distress Behavioral Patterns Among Latinos
Narratives of the mystical among users of psychedelics
Communalistic use of psychoactive plants as a bridge between traditional healing practices and Western medicine
Psychedelic medicine at a crossroads
Factors associated with psychedelic attitudes and usage among college students
Day trip to hell
Beyond prohibition
Psychosis and psychedelics
Macrodosing to microdosing with psychedelics
Go ask Alice, when she's 10-feet tall
Psilocybin for depression
Psychedelic therapy in the Czech Republic
Psychedelic therapy as a complementary treatment approach for alcohol use disorders
Anxiety, panic, and hopelessness during and after ritual ayahuasca intake in a woman with generalized anxiety disorder
Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics
A potential role for psilocybin in the treatment of obsessive-compulsive disorder
Minorities' Diminished Psychedelic Returns
Protective and risk factors associated with comorbid mental health disorders and psychological distress among Latinx subgroups
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Lysergic acid diethylamide (LSD) for alcoholism
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
Good practice in the conduct and reporting of survey research
Development of a rational scale to assess the harm of drugs of potential misuse
The role of religion and spirituality in mental health
Human hallucinogen research
Association of alcohol and drug use disorders and completed suicide
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
Screening for serious mental illness in the general population with the K6 screening scale
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease
Psychedelics and Mental Health
Curiosity and Exploration
Suicide
Hallucinogens
The entropic brain
Drug harms in the UK
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Psilocybin occasioned mystical-type experiences
Short screening scales to monitor population prevalences and trends in non-specific psychological distress
Suicide in the World
Voice of the Psychonauts
Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner
Values and Beliefs of Psychedelic Drug Users
Personality, Suicidal Ideation, and Reasons for Living among Older Adults
| Unique citing works | 93 |
|---|---|
| Citations per year | 9,3 |
| Citation span | 2016 - 2026 (11) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 83 |